214 related articles for article (PubMed ID: 36714553)
21. Smad7 in TGF-beta-mediated negative regulation of gut inflammation.
Monteleone G; Pallone F; MacDonald TT
Trends Immunol; 2004 Oct; 25(10):513-7. PubMed ID: 15364052
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut.
Fina D; Franzè E; Rovedatti L; Corazza GR; Biancone L; Sileri PP; Sica G; MacDonald TT; Pallone F; Di Sabatino A; Monteleone G
Mucosal Immunol; 2011 Mar; 4(2):239-44. PubMed ID: 20944558
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.
Del Zotto B; Mumolo G; Pronio AM; Montesani C; Tersigni R; Boirivant M
Clin Exp Immunol; 2003 Oct; 134(1):120-6. PubMed ID: 12974764
[TBL] [Abstract][Full Text] [Related]
24. Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine.
Monteleone I; Federici M; Sarra M; Franzè E; Casagrande V; Zorzi F; Cavalera M; Rizzo A; Lauro R; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2012 Nov; 143(5):1277-1287.e4. PubMed ID: 22819866
[TBL] [Abstract][Full Text] [Related]
25. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.
Monteleone G; Mann J; Monteleone I; Vavassori P; Bremner R; Fantini M; Del Vecchio Blanco G; Tersigni R; Alessandroni L; Mann D; Pallone F; MacDonald TT
J Biol Chem; 2004 Feb; 279(6):3925-32. PubMed ID: 14600158
[TBL] [Abstract][Full Text] [Related]
26. Smad7 Controls Immunoregulatory PDL2/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity.
Garo LP; Ajay AK; Fujiwara M; Beynon V; Kuhn C; Gabriely G; Sadhukan S; Raheja R; Rubino S; Weiner HL; Murugaiyan G
Cell Rep; 2019 Sep; 28(13):3353-3366.e5. PubMed ID: 31553906
[TBL] [Abstract][Full Text] [Related]
27. High Smad7 in the early post-operative recurrence of Crohn's disease.
Zorzi F; Calabrese E; Di Fusco D; De Cristofaro E; Biancone L; Casella S; Palmieri G; Monteleone G
J Transl Med; 2020 Oct; 18(1):395. PubMed ID: 33076905
[TBL] [Abstract][Full Text] [Related]
28. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
[TBL] [Abstract][Full Text] [Related]
29. TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases.
Marafini I; Troncone E; Salvatori S; Monteleone G
Pharmacol Res; 2020 May; 155():104757. PubMed ID: 32194176
[TBL] [Abstract][Full Text] [Related]
30. Smad7 interrupts TGF-β signaling in intestinal macrophages and promotes inflammatory activation of these cells during necrotizing enterocolitis.
MohanKumar K; Namachivayam K; Chapalamadugu KC; Garzon SA; Premkumar MH; Tipparaju SM; Maheshwari A
Pediatr Res; 2016 Jun; 79(6):951-61. PubMed ID: 26859364
[TBL] [Abstract][Full Text] [Related]
31. Clinical parameters of inflammatory bowel disease in children do not correlate with four common polymorphisms of the transforming growth factor β1 gene.
Liberek A; Jakóbkiewicz-Banecka J; Kloska A; Świderska J; Kmieć Z; Łuczak G; Wierzbicki P; Liberek T; Marek K; Plata-Nazar K; Sikorska-Wiśniewska G; Kamińska B; Węgrzyn G
Acta Biochim Pol; 2011; 58(4):641-4. PubMed ID: 22140658
[TBL] [Abstract][Full Text] [Related]
32. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease.
Monteleone G; Del Vecchio Blanco G; Monteleone I; Fina D; Caruso R; Gioia V; Ballerini S; Federici G; Bernardini S; Pallone F; MacDonald TT
Gastroenterology; 2005 Nov; 129(5):1420-9. PubMed ID: 16285943
[TBL] [Abstract][Full Text] [Related]
33. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
34. High SMAD7 and p-SMAD2,3 expression is associated with environmental enteropathy in children.
Syed S; Dinallo V; Iqbal NT; Di Iorio L; Di Fusco D; Guleria S; Amadi BC; Sadiq K; Moskaluk C; Ali SA; Kelly P; Monteleone G
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006224. PubMed ID: 29415065
[TBL] [Abstract][Full Text] [Related]
35. Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis.
Ma Y; Guan Q; Bai A; Weiss CR; Hillman CL; Ma A; Zhou G; Qing G; Peng Z
Inflamm Bowel Dis; 2010 Jun; 16(6):1040-50. PubMed ID: 19924805
[TBL] [Abstract][Full Text] [Related]
36. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
37. Novel therapeutic targets for inflammatory bowel disease.
Argollo M; Fiorino G; Hindryckx P; Peyrin-Biroulet L; Danese S
J Autoimmun; 2017 Dec; 85():103-116. PubMed ID: 28711286
[TBL] [Abstract][Full Text] [Related]
38. Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials.
Monteleone G; Stolfi C
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678723
[TBL] [Abstract][Full Text] [Related]
39. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.
Lee EO; Kang JL; Chong YH
J Biol Chem; 2005 Mar; 280(9):7845-53. PubMed ID: 15632190
[TBL] [Abstract][Full Text] [Related]
40. Smad7 and Colorectal Carcinogenesis: A Double-Edged Sword.
Troncone E; Monteleone G
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31052449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
